Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

CVC, ValueAct Confirm Intention Not To Make Offer For Misys - Quick Facts

CVC Capital Partners Ltd. and ValueAct Capital Master Fund, L.P. confirmed that they do not intend to proceed with an offer for Misys Plc (MSY.L, MUSJF.PK).

On March 5, 2012, funds advised by CVC and ValueAct had announced that they had concluded an agreement to work together with a view to making a recommended joint cash offer for Misys.

On March 19, Magic Bidco Ltd., an investment vehicle indirectly owned by funds managed or advised by Vista Equity Partners, LLC had announced a firm intention to make an offer for Misys pursuant to Rule 2.7 of the City Code on Takeovers and Mergers.

Click here to receive FREE breaking news email alerts for Misys plc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Apple Inc. said Tuesday after the markets closed that its third quarter profit rose 12% from last year, as sales surged and margins improved amid strong sales of its iPhones and Mac computers. The company's quarterly earnings per share also came in above analysts' expectations, but its quarterly sales fell short of analysts' forecast. United Nations Secretary-General Ban Ki-moon on Tuesday urged both Israelis and Palestinians to stop the fighting that has been raging for the past two weeks in the Gaza Strip, and pleaded with the two sides to return to dialogue with the aim of addressing the underlying causes of the repeated cycles... After moving notably higher in early trading on Tuesday, stocks continued to perform well throughout the session. The gains on the day offset the modest weakness that was seen in the previous session, extending the recent back-and-forth movement by the markets.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.